Literature DB >> 23419639

Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels.

Loredana Boccone1, Valentina Dessì, Antonella Meloni, Georgios Loudianos.   

Abstract

Allan-Herndon-Dudley syndrome (AHDS), an X linked condition, is characterized by severe intellectual disability, dysarthria, athetoid movements, muscle hypoplasia and spastic paraplegia in combination with altered TH levels, in particular, high serum T3 levels. Mutations in the MCT8 gene coding for the monocarboxylate thyroid hormone transporter 8 have been associated with AHDS. Here we describe a family with the presence of a MCT8 gene mutation, p.A224T, in three consecutive generations. In two generations its presence was detected in the hemizygous state in two males with neurological abnormalities including mental retardation, axial hypotonia, hypertonia of arms and legs and athetoid movements. One of them presented normal thyroid hormone levels. Mutation was also detected, although in the heterozygous state, in three females showing thyroid hormone levels in the normal range. Our results show the difficulty of distinguishing AHDS from patients with X-linked intellectual disability solely on the basis of clinical features and biochemical tests, and we advise screening for MCT8 mutations in either young or older patients with severe intellectual disability, axial hypotonia/dystonia, poor head control, spastic paraplegia, and athetoid movements even when they have normal thyroid hormone profiles.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23419639     DOI: 10.1016/j.ejmg.2013.02.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  11 in total

1.  Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.

Authors:  Soledad Bárez-López; Meredith D Hartley; Carmen Grijota-Martínez; Thomas S Scanlan; Ana Guadaño-Ferraz
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

2.  Few Amino Acid Exchanges Expand the Substrate Spectrum of Monocarboxylate Transporter 10.

Authors:  Jörg Johannes; Doreen Braun; Anita Kinne; Daniel Rathmann; Josef Köhrle; Ulrich Schweizer
Journal:  Mol Endocrinol       Date:  2016-05-31

Review 3.  Thyroid hormone transporters--functions and clinical implications.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

4.  Allan-Herndon-Dudley Syndrome: A Novel Pathogenic Variant of the SLC16A2 gene.

Authors:  Ramin Beheshti; Justen Aprile; Charles Lee
Journal:  Cureus       Date:  2022-01-31

5.  Novel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome.

Authors:  Keiko Shimojima; Koichi Maruyama; Masahiro Kikuchi; Ayako Imai; Ken Inoue; Toshiyuki Yamamoto
Journal:  Intractable Rare Dis Res       Date:  2016-08

Review 6.  Inherited defects of thyroid hormone-cell-membrane transport: review of recent findings.

Authors:  Jiao Fu; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-10       Impact factor: 3.243

7.  Altered behavioral performance and live imaging of circuit-specific neural deficiencies in a zebrafish model for psychomotor retardation.

Authors:  David Zada; Adi Tovin; Tali Lerer-Goldshtein; Gad David Vatine; Lior Appelbaum
Journal:  PLoS Genet       Date:  2014-09-25       Impact factor: 5.917

Review 8.  Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?

Authors:  Pieter Vancamp; Barbara A Demeneix; Sylvie Remaud
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-13       Impact factor: 5.555

9.  Transcriptomics reveal an integrative role for maternal thyroid hormones during zebrafish embryogenesis.

Authors:  Nadia Silva; Bruno Louro; Marlene Trindade; Deborah M Power; Marco A Campinho
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

10.  Clinical and Functional Consequences of C-Terminal Variants in MCT8: A Case Series.

Authors:  Ferdy S van Geest; Marcel E Meima; Kyra E Stuurman; Nicole I Wolf; Marjo S van der Knaap; Cláudia F Lorea; Fabiano O Poswar; Filippo Vairo; Nicola Brunetti-Pierri; Gerarda Cappuccio; Priyanka Bakhtiani; Sonja A de Munnik; Robin P Peeters; W Edward Visser; Stefan Groeneweg
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.